Menu
Stock Lookup
Search by symbol or company name, then inspect the chart and stock properties.
US
VNDA Vanda Pharmaceuticals Inc.
TradingView
As Of 8/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
5.1700
Day %
6.05%
RS
N/A
Ind Rank
#51
RS 1D
N/A
RS 1W
11
RS 1M
25
RS 3M
74
RS 6M
81
Consensus Rating
Buy
Current Quarter EPS
-0.53
Next Quarter EPS
-0.51
Current Year EPS
-2.18
Next Year EPS
-0.71
ExchangeUS
Market Cap1 B
52W High9.9400
From 52W High-47.99%
Open4.9500
High5.2600
Low4.9200
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-08-11
Bars Available310
Scanner Hits0
Last Scanner HitNever
Recent Scanner History
0 matching / 0 totalThis stock has not shown up in any persisted scanner results yet.
Analyst Snapshot
As Of 3/29/26| Consensus | Current Quarter EPS | Next Quarter EPS | Current Year EPS | Next Year EPS |
|---|---|---|---|---|
| Buy | -0.53 | -0.51 | -2.18 | -0.71 |
Based on 1 analysts offering recommendations for 'VNDA'.
Quarterly EPS Forecasts
5 rows| Period | Consensus EPS | High | Low | Estimates | Revisions |
|---|---|---|---|---|---|
| Mar 2026 | -0.53 | -0.49 | -0.57 | 2 |
▲
0
▼
0
|
| Jun 2026 | -0.51 | -0.51 | -0.51 | 2 |
▲
0
▼
0
|
| Sep 2026 | -0.43 | -0.32 | -0.54 | 2 |
▲
0
▼
0
|
| Dec 2026 | -0.43 | -0.26 | -0.60 | 2 |
▲
0
▼
0
|
| Mar 2027 | -0.28 | -0.28 | -0.28 | 1 |
▲
0
▼
0
|
Yearly EPS Forecasts
4 rows| Period | Consensus EPS | High | Low | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | -2.18 | -1.65 | -2.79 | 4 |
▲
0
▼
0
|
| Dec 2027 | -0.71 | -0.43 | -1.16 | 3 |
▲
0
▼
0
|
| Dec 2028 | 0.55 | 0.55 | 0.55 | 1 |
▲
0
▼
0
|
| Dec 2029 | 1.97 | 1.97 | 1.97 | 1 |
▲
0
▼
0
|